On Wednesday, the state Board of Pharmacy is scheduled to vote on new rules that would severely restrict Californians access to sterile compounded substances, including glutathione
Heat stroke: pathogenesis, diagnosis, and current treatment
McKendryJLowiszCVNanthakumarAMacDonaldMLimCCurrierBSet al
Drug type Dual GIP/GLP-1 receptor agonist Active ingredient Tirzepatide (same as Zepbound/Mounjaro) FDA status Not FDA-approved (compounded) 2026 legality Narrow 503A patient-specific only Typical cost ~$125$449/mo, self-pay Looking for a prescription provider route
They are also making substantial investments to meet anticipated demand at launch
A leaky or inflamed gut disrupts the entire hormonal and immune cascade, contributing to issues like chronic inflammation, autoimmune flares, and even mood imbalances